IMI2-2015-04-01
IMI2-2015-04-01
1 project · €1,130,000 total EU contribution (project-level) · 33 participating organizations · 10 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€1,130,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (7)
- France (6)
- BE (5)
- CH (3)
- Germany (3)
- Netherlands (3)
- DK (2)
- US (2)
- Italy (1)
- SE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AbbVie1 projects · UK
- AIFA1 projects · IT
- AMGEN1 projects · BE
- Astellas1 projects · UK
- ASTRAZENECA AB1 projects · SE
- Bayer Pharma AG1 projects · DE
- BII GMBH1 projects · DE
- ELI LILLY AND COMPANY LTD1 projects · UK
- EURORDIS - RARE DISEASES EUROPE1 projects · FR
- ROCHE1 projects · CH
- EFPIA1 projects · BE
- EUROPEAN PATIENTS FORUM1 projects · BE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890 ADAPT-SMART · 115890 | H2020 | €1,130,000 | €28,000 | Details |